Washington, D.C., (December 4, 2018) —MedStar Heart in partnership with CardioCell has been approved to conduct an investigational new drug clinical trial, called STEMVAD at MedStar Heart & Vascular Institute. The goal of this study is to determine whether stem cell therapy improves myocardial function in patients with severe heart failure. “Innovative therapies to improve heart function and outcomes of patients with advanced heart failure are sorely needed,” said Selma Mohammed, MD, PhD. Read more.
Recent Posts
- MedStar Health—Georgetown University Research Symposium and the Colloquium for Educators in the Health Professions – Register Today!
Don’t forget to register for the MedStar Health—Georgetown University Research Symposium and the... - MedStar Health Investigator Develops Risk Assessment Tool for Resuming Research in Low Resource Settings During the COVID-19 Pandemic
This collaborative research project sought to develop a framework to assess the risk of conducting c... - MedStar Health Researchers Examine Feasibility of a Telemedicine-Enabled Mental Health Intervention for Adults With Type 2 Diabetes
Collaborative research from MedStar Diabetes Institute, MedStar Health Research Institute, and the G...
Contact
Eva Hochberger
Communications & Planning Manager
Phone: 301-560-2917
[email protected]